Kaikai Industrial (600272), which holds shares in a number of listed companies, is now liquidated. On the evening of September 7, Kaikai Industrial disclosed that the company intends to choose the opportunity to sell stock assets, and currently holds the outstanding shares of 4 domestic A-share listed companies in China, namely Gan Consulting, Bank of Shanghai, Aijian Group and Xinhua Media, with a total initial investment cost of about 11.6666 million yuan. According to the latest closing price of the above 4 companies and the number of shares held by Kaikai Industry, the beijing business daily reporter found that the total market value of the shares of the above 4 companies held by Kaikai Industry is about 69.3547 million yuan, which is 57.6881 million yuan more than the initial investment cost, earning nearly 5 times. For the above use of funds, the staff of the office of the secretary of the board of directors of Kaikai Industry told the Beijing Business Daily reporter that it will be invested in the company's big health industry. In addition, on the evening of September 7, Kaikai Industry also disclosed a real estate purchase announcement, which intends to spend no more than 250 million yuan to acquire two properties under the controlling shareholder Shanghai Kaikai (Group) Co., Ltd. (hereinafter referred to as "Kaikai Group"), which is also to expand the company's medical sector business layout.
It has floated a profit of 57.6881 million yuan
On the evening of September 7, Kaikai Industrial said that the company intends to sell the circulating shares of the domestic A-share listed companies held by the company and its subsidiaries through secondary market transactions at an appropriate time and at a price not less than the initial investment cost.
It is understood that the circulating shares of domestic A-share listed companies currently held by Kaikai Industry and its subsidiaries include Gan Consulting, Bank of Shanghai, Aijian Group and Xinhua Media. Among them, the shares of Bank of Shanghai are held by Shanghai Kaikai Department Store Co., Ltd. (hereinafter referred to as "Kaikai Department Store"), and the shareholders of Kaikai Department Store are Shanghai Kai kai garment company (hereinafter referred to as "Kai Kai Garment") and Kai Kai Industry, which hold 60% and 40% of the shares of Kai Kai Department Store respectively, and Kai Kai Industrial holds 100% of the shares of Kai Kai Garment, so Kai Kai Garment is also a wholly-owned subsidiary of a listed company.
According to the announcement disclosed by Kaikai Industry, the initial investment cost of the shares held by the company in Gan Consulting, Bank of Shanghai, Aijian Group and Xinhua Media was about 10.542 million yuan, 920,200 yuan, 140,200 yuan and 64,200 yuan respectively; the corresponding number of shares held was about 6.2379 million shares, 1.4895 million shares, 96,500 shares and 118,800 shares, respectively.
According to the calculation of the Beijing Business Daily reporter, the initial investment cost of the shares of the above four companies held by Kaikai Industry is about 11.6666 million yuan.
As of the close of trading on September 7, the stock prices of Gan Consulting, Bank of Shanghai, Aijian Group and Xinhua Media were quoted at 9.13 yuan / share, 7.5 yuan / share, 7.38 yuan / share and 4.37 yuan / share, respectively, according to the number of shares held by 6.2379 million shares, 1.4895 million shares, 96,500 shares and 118,800 shares, and the market value of the shares of the above four companies held by Kaikai Industrial was about 56.952 million yuan, 11.1713 million yuan, 712,200 yuan and 519,200 yuan, respectively.
According to calculations, the shares of Gan Consulting, Bank of Shanghai, Aijian Group and Xinhua Media held by Kaikai Industry have now floated profits of 46.41 million yuan, 10.2511 million yuan, 572,000 yuan and 455,000 yuan respectively, earning 4.4 times, 11.14 times, 4.1 times and 7.1 times respectively.
In total, the total market value of the shares of the above four companies currently held by Kaikai Industry is 69.3547 million yuan, which is 57.6881 million yuan compared with the total initial investment cost of 11.6666 million yuan, earning 4.94 times. Kaikai Industrial said that in accordance with the relevant provisions of the relevant new financial instrument standards such as the Accounting Standards for Business Enterprises, the company designates the outstanding shares of domestic A-share listed companies held by the company as financial assets measured at fair value and the changes of which are included in other comprehensive income, and uses the account of "investment in other equity instruments". The company's share sale transaction will not affect the company's current profit and post-period profit.
Looking at the above four companies, in addition to the Bank of Shanghai, the remaining 3 are veteran enterprises in the capital market, and Gan Consulting, Aijian Group and Xinhua Media landed on A shares in 1997, 1993 and 1994 respectively.
Wang Chikun, an independent economist, told the Beijing Business Daily reporter that for listed companies, the timely sale of profitable shares is conducive to improving the liquidity and efficiency of the company's assets.
For the purpose of this transaction, Kaikai Industry also said in the announcement that it is conducive to optimizing the company's asset structure and meeting the company's future development capital needs. In view of the specific use of the funds, the Beijing Business Daily reporter called the office of the secretary of the board of directors of Kaikai Industry for an interview, and the staff of the other party said that it would be invested in the development of the company's big health industry.
Spend huge sums of money to buy real estate and increase medical treatment
As a "pharmaceutical + clothing" dual main business listed company, Kaikai Industry pays more attention to the development of the company's pharmaceutical sector and continues to increase medical treatment.
On the evening of September 7, Kaikai Industry also disclosed a real estate purchase announcement, the company and its wholly-owned subsidiary Shanghai Lei YunShang Pharmaceutical West District Co., Ltd. intend to purchase two properties located in Wuding Road and Jiangchang West Road, Jing'an District, Shanghai, respectively, from the company's controlling shareholder Kaikai Group, kaikai group has obtained the property rights certificates of the above two properties, the real estate area is 4013.7 square meters, 3668.76 square meters, pre-assessment by an asset appraisal agency with securities and futures business qualifications, The pre-appraisal price of the above-mentioned real estate is 140 million yuan (including VAT) and 110 million yuan (including VAT), respectively, and the total final transaction price will not be higher than 250 million yuan.
The equity relationship shows that Kaikai Group holds 26.51% of the shares of Kaikai Industry and is the largest shareholder of the listed company.
Kaikai Industry said that the funds to be purchased for the related party transaction are the company's own funds, which will not have a significant impact on the company's operating cash flow, and will not have a significant impact on the company's daily operation and financial situation. According to the data, as of the end of the first half of this year, the monetary funds on the account of the opening industry were about 234 million yuan.
For the purpose of this large-scale purchase of real estate, Kaikai Industry also said that in order to comprehensively promote the company's "big health" strategy and implement the three-wheel drive development strategy of medicine, medical treatment and medical care, it intends to use the real estate to expand the business layout of the medical sector and explore the possibility of opening self-operated medical institutions.
It is worth mentioning that for a large capital investment of 250 million yuan, Kaikai Industry said that the specific business to be invested by the company has not yet been determined.
Medical reform expert Wei Ziming told the Beijing Business Daily reporter that the current opening of domestic self-operated medical institutions is mainly affected by factors such as the external environment, market changes, industry policies, doctor resources and consumption habits, and needs to go through a strict project approval process, the project cultivation period is long, and the investment income may be difficult to show in the short term.
Kaikai Industry also prompted the risk that the initial investment of newly established self-operated medical institutions is large, the general investment recovery period is 3-5 years, and depreciation costs and decoration costs will have a certain negative impact on the company's profits in the early stage of operation.
According to financial data, Kaikai Industrial achieved operating income of about 336 million yuan in the first half of this year, down 14.75% year-on-year; the corresponding attributable net profit was about 5.945 million yuan, up 51.57% year-on-year. In addition to the pharmaceutical industry, Kaikai Industry also has a garment industry, mainly engaged in the production, wholesale and retail of Chinese time-honored "Kaikai" brand clothing.
However, judging from the capital actions of listed companies this year, Kaikai Industry is constantly increasing the size of medicine.
Beijing Business Daily reporter Ma Changchang
![It's a big deal, and I spent the weekend happily, but after I came back, the company ran away, and the salary of more than 100,000 yuan was not paid.[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)